TechCare: Mobile-AssessmenT and ThErapy for PsyCHosis: An Intervention for Clients Within the EArly InteRvention SErvice
Launched by LANCASHIRE CARE NHS FOUNDATION TRUST · May 6, 2015
Trial Information
Current as of June 12, 2025
Unknown status
Keywords
ClinConnect Summary
This feasibility study will follow the NIHR guidance on feasibility study design (NIHR, 2014) and will consist of both qualitative and quantitative components. The study will run across three strands as follows 1) Qualitative work \& Systematic review 2) Test run and Intervention refinement 3) Feasibility trial.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Each client must be accepted into the Psychosis Group of the Lancashire Early Intervention Service.
- • Ages 18 - 35 years
- • Medication stable for previous two months
- • Clients must be currently stable-The Lancashire Early Intervention Team uses a traffic light system to indicate current symptomatology and risks of each client. For this study we will use only clients with a Green Light, signifying that they are currently stable.
- • A score of 3 or more on positive symptoms on the PANSS
- • Minimum score of 1 on the Calgary depression scale.
- Exclusion Criteria:
- • Drug induced psychosis
- • An acquired brain injury or learning disability
- • Clients who are undergoing assessment, not formally diagnosed and accepted into the service.
- • Lacking capacity for informed consent.
- • Ultra High Risk of Developing Psychosis Group (i.e. Prodromal, not first episode)
About Lancashire Care Nhs Foundation Trust
Lancashire Care NHS Foundation Trust is a leading healthcare organization in the United Kingdom, dedicated to providing high-quality mental health, learning disability, and community health services. As a prominent clinical trial sponsor, the Trust is committed to advancing medical research and improving patient outcomes through innovative studies. With a focus on collaboration, ethical practices, and patient-centered care, Lancashire Care NHS Foundation Trust actively engages in clinical trials that aim to enhance treatment options and contribute to the evidence base for healthcare practices. Their multidisciplinary approach ensures that trials are conducted with the utmost integrity and scientific rigor, reflecting their dedication to excellence in clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Preston, Lancashire, United Kingdom
Patients applied
Trial Officials
Imran B Chaudhry, MBBS MD
Principal Investigator
Lead Consultant Psychiatrist, Lancashire Care Early Intervention Service & Hon Clinical Professor Adult Psychiatry University of Manchester
Nusrat Husain, MBBS MD
Principal Investigator
Reader in Psychiatry University of Manchester, Director Research Global Health Manchester Academic Health Sciences Centre & Consultant Psychiatrist Lancashire Care Early Intervention Service
James Kelly, DClinPsych
Principal Investigator
Lancashire Care NHS Foundation Trust Early Intervention Service
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials